Haleon (LON:HLN) Trading Up 0.4% – Should You Buy?

Haleon plc (LON:HLN) shot up 0.4% during mid-day trading on Friday . The stock traded as high as GBX 383.50 ($4.84) and last traded at GBX 381.97 ($4.82). 19,355,100 shares traded hands during mid-day trading, a decline of 1% from the average session volume of 19,493,533 shares. The stock had previously closed at GBX 380.60 ($4.80).

Haleon Stock Up 0.4 %

The firm has a market capitalization of £34.53 billion, a price-to-earnings ratio of 3,183.08, a P/E/G ratio of 1.49 and a beta of 0.19. The company has a debt-to-equity ratio of 54.18, a current ratio of 0.84 and a quick ratio of 0.93. The stock has a fifty day moving average of GBX 374.30 and a two-hundred day moving average of GBX 362.40.

Insider Transactions at Haleon

In other news, insider Dawn Allen sold 74,679 shares of the company’s stock in a transaction dated Thursday, November 21st. The shares were sold at an average price of GBX 372 ($4.70), for a total transaction of £277,805.88 ($350,632.18). Also, insider Alan Stewart purchased 33,923 shares of the company’s stock in a transaction that occurred on Wednesday, November 6th. The shares were purchased at an average cost of GBX 368 ($4.64) per share, for a total transaction of £124,836.64 ($157,562.34). Corporate insiders own 10.74% of the company’s stock.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.